Combined PRF of the Pudendal Nerve With Ganglion Impar Block Effectively Alleviates Pudendal Neuralgia
PRF
Combined Pulsed Radiofrequency of the Pudendal Nerve With Ganglion Impar Block Effectively Alleviates Pudendal Neuralgia
1 other identifier
interventional
40
1 country
1
Brief Summary
Patients with pudendal neuralgia suffer from long-term pain, which severely affects their quality of life. Due to unclear etiology, there is a lack of specific treatment methods. The aim of this study is to evaluate the efficacy of combined pulsed radiofrequency with ganglion impar block therapy helps evaluate the effectiveness of this treatment method for pudendal neuralgia, comparing it with traditional treatments or single interventions, and providing guidance for clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 6, 2024
CompletedFirst Posted
Study publicly available on registry
June 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJune 17, 2024
June 1, 2024
1.7 years
June 6, 2024
June 11, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Patient Global Impression of Change
0 -100%#0=no change,100%= complete relief of pain symptoms.
1month
Patient Global Impression of Change
0 -100%#0=no change,100%= complete relief of pain symptoms.
2months
Patient Global Impression of Change
0 -100%#0=no change,100%= complete relief of pain symptoms.
3months
Patient Global Impression of Change
0 -100%#0=no change,100%= complete relief of pain symptoms.
6months
Secondary Outcomes (4)
Numeric Rating Scale
1month
Numeric Rating Scale
2months
Numeric Rating Scale
3months
Numeric Rating Scale
6months
Study Arms (1)
enrolled patients
EXPERIMENTALEnrolled patients underwent pulsed radiofrequency of the pudendal nerve combined with ganglion impar block after pudendal nerve diagnostic block
Interventions
Combined pulsed radiofrequency of the pudendal nerve with ganglion impar block
Eligibility Criteria
You may qualify if:
- Age between 18 and 80 years old;
- Diagnosis of pudendal neuralgia meets the Nantes criteria. essential criteria include the following:1)Pain in the territory of the pudendal nerve;2) Pain is predominantly experienced while sitting;3) The pain does not wake the patient at night;4)Pain with no objective sensory impairment;5)Pain relieved by diagnostic pudendal nerve block;
- Received conservative treatment for more than 3 months, and either had poor response to conservative treatment or intolerable medication side effects.
- Capable of signing informed consent form.
You may not qualify if:
- Pain caused by pelvic malignant diseases or autoimmune diseases;
- Pain caused by pelvic surgery;
- Taking anticoagulant drugs or having abnormal coagulation function;
- Pregnancy;
- Systemic infectious diseases;
- Inability to complete scale assessments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
People's Hospital of Peking University
Beijing, Beijing Municipality, 100044, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yiming Liu, MD
Peking University People's Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- director of department of Anesthesiology and Pain medicine
Study Record Dates
First Submitted
June 6, 2024
First Posted
June 17, 2024
Study Start
May 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
June 17, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share